316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A

by Aurélien Marabelle, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Paul Frohna, Christiane Jungels, Norbert Vey, Elena Garralda, Marina Iché
Published 2020-11-01

211 Targeting BTN2A1 modulates anti-tumor activity of Vg9Vd2 T cells

by Carla Cano, Aude de Gassart, Christine Pasero, Melanie Gabriac, Marie Fullana, Emilie Granarolo, HOET Rene, Caroline Imbert, Laurent Gorvel, Antoine Briantais, Anne-Charlotte Le Floch, Daniel Olive
Published 2020-11-01

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells

by Carla E. Cano, Christine Pasero, Aude De Gassart, Clement Kerneur, Mélanie Gabriac, Marie Fullana, Emilie Granarolo, René Hoet, Emmanuel Scotet, Chirine Rafia, Thomas Hermman, Caroline Imbert, Laurent Gorvel, Norbert Vey, Antoine Briantais, Anne Charlotte le Floch, Daniel Olive
Published 2021-07-01